KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Gross Profit (2016 - 2025)

Boston Scientific (BSX) has disclosed Gross Profit for 17 consecutive years, with $3.7 billion as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 18.87% to $3.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.9 billion through Dec 2025, up 20.58% year-over-year, with the annual reading at $13.9 billion for FY2025, 20.57% up from the prior year.
  • Gross Profit hit $3.7 billion in Q4 2025 for Boston Scientific, up from $3.5 billion in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $3.7 billion in Q4 2025 to a low of $1.9 billion in Q1 2021.
  • Historically, Gross Profit has averaged $2.6 billion across 5 years, with a median of $2.5 billion in 2023.
  • Biggest five-year swings in Gross Profit: surged 75.91% in 2021 and later increased 3.57% in 2022.
  • Year by year, Gross Profit stood at $2.2 billion in 2021, then increased by 3.57% to $2.2 billion in 2022, then rose by 15.55% to $2.6 billion in 2023, then rose by 20.01% to $3.1 billion in 2024, then grew by 18.87% to $3.7 billion in 2025.
  • Business Quant data shows Gross Profit for BSX at $3.7 billion in Q4 2025, $3.5 billion in Q3 2025, and $3.4 billion in Q2 2025.